Tram Bui
Contacto de Relaciones con Inversores en HALOZYME THERAPEUTICS, INC. .
Origen de la red de primer grado Tram Bui.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
| Public Company | Biotechnology | 16 | |
| Subsidiary | Pharmaceuticals: Major | 6 | |
KCSA Strategic Communications
 KCSA Strategic Communications Miscellaneous Commercial ServicesCommercial Services KCSA Strategic Communications provides public relations services. It offers Investor Relations, Public Relations, Naming & Corporate Identity, Web Design & Development, Online Marketing, Media Planning, Advertising and Social Media services. The company was founded in 1969 and is headquartered in New York, NY.
1
| Private Company | Miscellaneous Commercial Services | 1 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Tram Bui a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| The Royal College of Physicians | College/University | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| University of California San Diego | College/University | Undergraduate Degree Undergraduate Degree | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Comptroller/Controller/Auditor Corporate Officer/Principal | |
| QUALCOMM, INC. | Semiconductors | Director/Board Member Corporate Officer/Principal | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| ADC THERAPEUTICS SA | Pharmaceuticals: Major | Director/Board Member | |
| COMPUGEN LTD. | Biotechnology | Director/Board Member | |
| Aventis, Inc. | Chief Tech/Sci/R&D Officer | ||
International Drug Development Institute SA
 International Drug Development Institute SA Miscellaneous Commercial ServicesCommercial Services International Drug Development Institute SA engages in the provision of biostatistics and electronical-clinical solutions for phase I-IV clinical trials. It offers oncology clinical research, consultancy, clinical data management, data standards implementation and randomization services. The company was founded by Marc Buyse in 1991 and is headquartered in Louvain-la-Neuve, Belgium. | Miscellaneous Commercial Services | Director/Board Member | |
Rhone Poulenc Rorer
 Rhone Poulenc Rorer Chemicals: SpecialtyProcess Industries Part of Solvay SA, Rhone Poulenc Rorer is a French pharmaceutical company that manufactures and distributes pharmaceutical products. | Chemicals: Specialty | Corporate Officer/Principal | |
| Wellesley College | College/University | Undergraduate Degree | |
NETRIS Pharma SAS
 NETRIS Pharma SAS BiotechnologyHealth Technology NETRIS Pharma SAS develops targeted therapies for the treatment of cancer. The company is based in Lyon, France. The French company was founded in 2008 by Patrick Mehlen, Agnès Bernet. Patrick Mehlen has been the CEO since 2008. | Biotechnology | Chairman | |
| APREA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Evercore Capital Partners
 Evercore Capital Partners Investment ManagersFinance Evercore Capital Partners (Evercore Capital) is a private equity subsidiary of Evercore Group LLC founded in 1996 by Roger C. Altman. The firm is headquartered in New York. | Investment Managers | Private Equity Investor | |
Oxford BioTherapeutics Ltd.
 Oxford BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Oxford BioTherapeutics Ltd. develops antibody-based medicines for oncology. The firm offers antibody-based cancer drugs with integrated diagnostics against novel targets. The company was founded by Christian Rohlff in 2003 and is headquartered in Abingdon, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| VAXCYTE, INC. | Biotechnology | Director of Finance/CFO | |
Cirius Therapeutics, Inc.
 Cirius Therapeutics, Inc. BiotechnologyHealth Technology Cirius Therapeutics, Inc. operates as a biotechnology company. It offers metabolic treatment for nonalcoholic steatohepatitis. The company was founded by Jerry R. Colca and Brian Finck and was founded in March 2017, and is headquartered in San Diego, CA. | Biotechnology | Director/Board Member | |
| DYNAVAX TECHNOLOGIES CORPORATION | Biotechnology | Director/Board Member | |
Mammoth Biosciences, Inc.
 Mammoth Biosciences, Inc. Internet Software/ServicesTechnology Services Mammoth Biosciences, Inc. operates CRISPR-based platform for disease detection. The firm offers its services under the categories of bioinformatics, biotechnology, genetics, health diagnostics and life science. The company was founded by Ashley Tehranchi, Janice Chen, Jennifer A. Doudna, Lucas Harrington and Trevor Martin and is headquartered in South San Francisco, CA. | Internet Software/Services | Director of Finance/CFO | |
Asher Biotherapeutics, Inc.
 Asher Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Asher Biotherapeutics, Inc. engages in the research and development of immunotherapy for cancer. The company was founded by Ivana Djuretic and Andy Yeung in 2019 and is headquartered in South San Francisco, CA. | Miscellaneous Commercial Services | Director/Board Member | |
Synergie Lyon Cancer
 Synergie Lyon Cancer Miscellaneous Commercial ServicesCommercial Services Synergie Lyon Cancer provides health care services. It focuses on research efforts on cancer escape, apoptosis and senescence and Immune surveillance. The company was founded in 2007 and is headquartered in Lyon, France. | Miscellaneous Commercial Services | President | |
| Stanford University | College/University | Masters Business Admin | |
iTeos Therapeutics SA
 iTeos Therapeutics SA Pharmaceuticals: MajorHealth Technology iTeos Therapeutics SA engages in the discovery of immunomodulators for cancer therapy. It operates as a biotechnology company which focuses on targeting metabolism of the tumor microenvironment through development of small-molecule immunomodulators for cancer treatment. The firm develops small molecules designed to target the tumor microenvironment by inhibiting cancer-induced immune suppression. Targeting such resistance mechanisms will enhance the clinical efficacy of both standards of care treatments as well as the newer immunomodulatory therapies based on the blockade of immune checkpoints. The company was founded in 2011 by Michel Detheux and Benoit Van den Eynde and is headquartered in Gosselies, Belgium. | Pharmaceuticals: Major | Director/Board Member | |
| ZYLA LIFE SCIENCES | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ARGENX SE | Pharmaceuticals: Other | Director/Board Member | |
| COHERUS BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member | |
| MADRIGAL PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| ORACLE CORPORATION | Packaged Software | Sales & Marketing | |
| COUPA SOFTWARE INCORPORATED | Packaged Software | Sales & Marketing | |
Astellas Pharma US, Inc.
 Astellas Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma US, Inc. manufactures pharmaceutical products. It offers cardiology, dermatology, immunology, infectious diseases, and urology. The firm was founded in 2005 and is headquartered in Northbrook, IL. | Pharmaceuticals: Major | Sales & Marketing | |
| Alfred University | College/University | Undergraduate Degree | |
| TRANSGENE | Biotechnology | Director/Board Member | |
| Sanofi-Aventis Pharmaceuticals | Corporate Officer/Principal | ||
| CELATOR PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member | |
| University of Nice Sophia Antipolis | College/University | Doctorate Degree | |
| PIERIS PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
Theravectys SAS
 Theravectys SAS BiotechnologyHealth Technology Theravectys SAS provides biotechnology research services. It is working on the development of a therapeutic vaccine against HIV. The company was founded on May 17, 2005 and is headquartered in Paris, France. | Biotechnology | Director/Board Member | |
| CELGENE | Biotechnology | Corporate Officer/Principal | |
| European Organisation for Research & Treatment of Cancer | Director/Board Member | ||
| VALERIO THERAPEUTICS | Pharmaceuticals: Major | Director/Board Member |
Estadísticas
Internacional
| Estados Unidos | 35 |
| Francia | 8 |
| Bélgica | 4 |
| Reino Unido | 3 |
| Suiza | 2 |
Sectorial
| Health Technology | 29 |
| Consumer Services | 9 |
| Commercial Services | 4 |
| Technology Services | 4 |
| Process Industries | 3 |
Operativa
| Director/Board Member | 80 |
| Corporate Officer/Principal | 55 |
| Independent Dir/Board Member | 45 |
| Undergraduate Degree | 20 |
| Chairman | 14 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Jean Bizzari | 24 |
| Barbara Duncan | 22 |
| Matthew Posard | 19 |
| Jeffrey Henderson | 18 |
| James Daly | 13 |
| Helen Torley | 12 |
| Connie Matsui | 11 |
| Bernadette Connaughton | 10 |
| Elaine Sun | 10 |
| Carmen Volkart | 9 |
| Akiko Miyashita | 9 |
| John J. Howarth | 8 |
| Peter Richardson | 8 |
| Patrick Michael Shea | 7 |
| Michael LaBarre | 6 |
- Bolsa de valores
- Insiders
- Tram Bui
- Conexiones Empresas
